Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CRN campaign

This article was originally published in The Tan Sheet

Executive Summary

Large print ads touting the benefits of supplements will appear in Roll Call, The Hill to complement CRN's mail, email campaign aimed at congressional members and staffers, the trade group announces June 23. Ads and fact sheets carry tagline "DSHEA: It Makes Sense...Let's Make It Work" (1"The Tan Sheet" May 19, 2003, In Brief). Black and white ads will run nine times between June and September, CRN notes. Monthly color ads sent by mail will feature information on ginkgo, antioxidants, fatty acids, other supplements. Mail campaign will continue until December, at which point CRN will evaluate the campaign's impact...

You may also be interested in...



CRN lobbying effort

Trade group fact sheet explaining health, financial benefits of daily multivitamin use sent to more than 500 Congressional offices on May 12. 1Multivitamin fact sheet represents first in a series of such letters that will be sent monthly to Hill staffers; next fact sheet will feature calcium supplements. CRN has initiated campaign to educate Congress on supplements and to counter negative image of industry conveyed by mass media. Trade group aims to remind Congress members and their staff that supplement industry can be regulated adequately under DSHEA and contributes many products that are beneficial to public health. Each fact sheet will carry the slogan: "DSHEA: It makes sense...Let's make it work"...

Pharma Can Pursue Claims Against Providers For 340B Duplicate Discounts In Medicaid Managed Care, HRSA Says

The statement, which is part of a final rule on the 340B administrative dispute resolution process, could facilitate manufacturer efforts to seek repayments from hospitals in such cases.

The Aspirin Test For AI?

US FDA Commissioner Robert Califf tells Congress that regulators don’t have to know how artificial intelligence works in medicine, but must make very sure it actually does work.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS095603

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel